← FDA DRUG APPROVALS

FDA ANDA · ANDA202725

QUINAPRIL

quinapril hydrochloride

Sponsor: AUROBINDO PHARMA LTD

APPLICATION
ANDA202725
TYPE
ANDA
ORIGINAL APPROVAL
2013-04-29
LATEST ACTION
2022-03-31
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

QUINAPRIL HYDROCHLORIDEPrescription
QUINAPRIL HYDROCHLORIDE EQ 40MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEPrescription
QUINAPRIL HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEPrescription
QUINAPRIL HYDROCHLORIDE EQ 20MG BASE · TABLET · ORAL
QUINAPRIL HYDROCHLORIDEPrescription
QUINAPRIL HYDROCHLORIDE EQ 5MG BASE · TABLET · ORAL

Approval history

2022-03-31Labeling · Supplement 13 · standardAP
2018-06-08Labeling · Supplement 8 · standardAP
2018-06-08Labeling · Supplement 7 · standardAP
2015-11-24Labeling · Supplement 6 · standardAP
2015-11-24Labeling · Supplement 5 · standardAP
2014-09-26Labeling · Supplement 3 · standardAP
2014-09-26Labeling · Supplement 2 · standardAP
2013-04-29UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →